Search Results1-7 of  7

  • Omuro Yasushi ID: 9000019002929

    Articles in CiNii:1

    • Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer : a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study (2012)
  • Omuro Yasushi ID: 9000329006942

    Articles in CiNii:1

    • Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW : a randomized clinical trial in second-line treatment of gastric cancer (2016)
  • Omuro Yasushi ID: 9000390405158

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • Omuro Yasushi ID: 9000398634437

    Articles in CiNii:1

    • Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients : a phase 2, open-label study (2018)
  • Omuro Yasushi ID: 9000401420838

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • OMURO Yasushi ID: 9000237595072

    がん・感染症センター都立駒込病院化学療法科 (2012 from CiNii)

    Articles in CiNii:3

    • Three times high-dose chemotherapy and peripheral blood stem cell transplantation rescue for patient with refractory ovarian germ cell tumor (2002)
    • 消化器がんと化学療法 (特集 ここまで知っておきたい! 最新がん化学療法と看護 Q&A) -- (各種がんにおける化学療法) (2005)
    • PD-3-1 腹腔洗浄細胞診陽性(CY1),stageIV胃癌に対する手術を含めた集学的治療の有用性(PD-3 パネルディスカッション(3)Stage IV胃癌に対する集学的治療,第112回日本外科学会定期学術集会) (2012)
  • Omuro Yasushi ID: 9000403150557

    Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan (2020 from CiNii)

    Articles in CiNii:1

    • Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer (2020)
Page Top